Behind the Mystery: Understanding Blastic Plasmacytoid Dendritic Cell Neoplasm
September 4, 2019
Signs, Symptoms, and Treatments
Behind the Mystery takes a closer look at Blastic Plasmacytoid Dendritic Cell Neoplasm, a rare disease that is often misdiagnosed and affects at least 500 to 1,000 patients each year in the U.S.
Historically, the median survival from the time of diagnosis is anywhere from 8 to 14 months, and without treatment, BPDCN is oftentimes fatal.
The Balancing Act visited the Moffitt Cancer Center in Tampa, Florida to learn about BPDCN from oncologist Dr. Kendra Sweet. She shares the prevalence, who it can affect, and how it can present, as well as treatment options for patients.
Patient Dan Dan Beres was enjoying life with his wife when his diagnosis came out of nowhere. We will hear his story, as well as advice and guidance for patients diagnosed.
Bringing the best tips from the experts in Atlanta in business, beauty, wealth management, child healthcare, car shopping, and more. Each year, Atlanta’s Women’s Entrepreneurship Initiative selects 15 local female entrepreneurs for a 15-month business training program. We meet women who have grown their companies, created jobs, and broke through the glass ceiling. With some […]
iMCD is the deadliest subtype of Castleman disease. Approximately one third of patients die within five years of diagnosis, and another third die within 10 years if not treated.
There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades.